Clinical Trials · NCT00240045

The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction

CompletedPhase 2/Phase 3Octreotide (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
University of Alberta
Enrollment
9
Start date
Oct 2005
Locations
1 site, Canada
Primary endpoint
Improvement in renal function (creatinine)
View Octreotide compound reference